BMS-P5 free base
BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma.Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression.
Product Specifications
CAS Number
1550371-22-6
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 250 mg/mL (529.01 mM)
Smiles
O=C (N1[C@@H] (C) CC[C@@H] (N) C1) C2=CC (OC) =C3C (N=C (C4=CC5=CC=CN=C5N4CC6CC6) N3C) =C2
Molecular Formula
C27H32N6O2
Molecular Weight
472.58
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Transcription Factor p65 Acetyl-Lys218 (RELA AcK218) Antibody
Transcription Factor p65 Acetyl-Lys218 (RELA AcK218) Antibody
Monoclonal Fc gamma RIIB/CD32b Antibody Pair [HRP]
